chronic occlusive lesions of lower extremity femoral-popliteal artery
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged between 18 and 80 years; 2. Lower extremity arterial occlusion (PAD) with Rutherford rating between 2 and 5; 3. Common femoral artery, superficial femoral artery, popliteal artery (= 70%) or occlusional lesions; 4. Lesion type: atherosclerotic plaque; Calcified plaque; Fibrotic plaque; 5. The total length of lesions is not limited; 6. Be able to make sense for the purpose of the study and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with plasma Cr level more than 150 mumol/L; 2. Acute and subacute thrombosis patients requiring thrombolysis and thrombolysis removal; 3. Patients with non-transluminal lesions; 4. Patients who are known to be allergic to aspirin, heparin, bolivar, contrast agent, etc.; 5. Patients who have participated in the clinical trial of drugs or other medical devices that may interfere with this clinical trial in the past 3 months; 6. Pregnant and lactating women; 7. Patients with thrombocytopenic purpura or coagulation dysfunction; 8. Patients with a life expectancy of less than 12 months; 9. Patients who are unable or unwilling to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| primary patency rate of target leisions for 12 months; | — |
Countries
China
Contacts
Tianjin Medical University